Sign In

Save up to 80% by drug discount in your pharmacy with "Pharmacy Near Me - National Drug Discount Card"

You can scan QR Code(just open camera on your phone/scan by application) from the image on prescription drug discount card to save it to your mobile phone. Or just click on image if you're on mobile phone.

View Generic:
View Brand:

Yves saint laurent all hours foundation broad spectrum spf 20 sunscreen luminous matte foundation - Medication Information

Product NDC Code 49967-712
Drug Name

Yves saint laurent all hours foundation broad spectrum spf 20 sunscreen luminous matte foundation

Type Brand
Active Ingredients
Octinoxate 67 mg/ml
Titanium dioxide 11 mg/ml
Route TOPICAL
Dosage Form LOTION
Application Number M020
Labeler Name L'Oreal USA Products Inc
Packages
Package NDC Code Description
49967-712-01 1 bottle in 1 carton (49967-712-01) / 25 ml in 1 bottle
49967-712-02 4.2 ml in 1 package (49967-712-02)
49967-712-03 1 ml in 1 packet (49967-712-03)
Check if available Online

Active ingredient

A list of the active, medicinal ingredients in the drug product.
Active ingredientS Octinoxate 6.7% Titanium dioxide 3.6%

Dosage and administration

Information about the drug product’s dosage and administration recommendations, including starting dose, dose range, titration regimens, and any other clinically sigificant information that affects dosing recommendations.
Directions For sunscreen use: shake well before use apply liberally 15 minutes before sun exposure reapply at least every 2 hours use a water resistant sunscreen if swimming or sweating Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including: limit time in the sun, especially from 10 a.m. - 2 p.m. wear long-sleeved shirts, pants, hats and sunglasses children under 6 months of age: Ask a doctor

Inactive ingredient

A list of inactive, non-medicinal ingredients in a drug product.
Inactive ingredients water, dimethicone, isododecane, alcohol denat., trimethylsiloxysilicate, butylene glycol, PEG-10 dimethicone, synthetic fluorphlogopite, perlite, disteardimonium hectorite, nylon-12, HDI/trimethylol hexyllactone crosspolymer, aluminum hydroxide, isopropyl lauroyl sarcosinate, diisopropyl sebacate, bis-PEG/PPG-14/14 dimethicone,magnesium sulfate, phenoxyethanol, disodium stearoyl glutamate, aluminum hydroxide, dipentaerythrityl tetrahydroxystearate/tetraisostearate, silica silylate, glycerin, tocopherol, caprylic/capric triglyceride, hydrogen dimethicone, silica, BHT, jasminum officinale (jasmine) flower extract, benzyl alcohol, sodium hyaluronate, phenethyl alcohol, linalool, sodium carrageenan, citrus limon (lemon) peel extract, jania rubens extract, fragrance; may contain: iron oxides, titanium dioxide

Indications and usage

A statement of each of the drug products indications for use, such as for the treatment, prevention, mitigation, cure, or diagnosis of a disease or condition, or of a manifestation of a recognized disease or condition, or for the relief of symptoms associated with a recognized disease or condition. This field may also describe any relevant limitations of use.
Uses helps prevent sunburn if used as directed with other sun protection measures (see Directions ) , decreases the risk of skin cancer and early skin aging caused by the sun

Purpose

Information about the drug product’s indications for use.
Purpose Sunscreen

Spl product data elements

Usually a list of ingredients in a drug product.
Yves Saint Laurent All Hours Foundation Broad Spectrum SPF 20 Sunscreen Luminous Matte Foundation Octinoxate and Titanium Dioxide OCTINOXATE OCTINOXATE TITANIUM DIOXIDE TITANIUM DIOXIDE WATER DIMETHICONE ISODODECANE ALCOHOL TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8) BUTYLENE GLYCOL MAGNESIUM POTASSIUM ALUMINOSILICATE FLUORIDE PEG-10 DIMETHICONE (600 CST) PERLITE DISTEARDIMONIUM HECTORITE NYLON-12 HEXAMETHYLENE DIISOCYANATE/TRIMETHYLOL HEXYLLACTONE CROSSPOLYMER ISOPROPYL LAUROYL SARCOSINATE DIISOPROPYL SEBACATE BIS-PEG/PPG-14/14 DIMETHICONE MAGNESIUM SULFATE, UNSPECIFIED FORM PHENOXYETHANOL DISODIUM STEAROYL GLUTAMATE DIPENTAERYTHRITYL TETRAHYDROXYSTEARATE/TETRAISOSTEARATE GLYCERIN TOCOPHEROL MEDIUM-CHAIN TRIGLYCERIDES HYDROGEN DIMETHICONE (13 CST) SILICON DIOXIDE BUTYLATED HYDROXYTOLUENE JASMINUM OFFICINALE FLOWER BENZYL ALCOHOL HYALURONATE SODIUM PHENYLETHYL ALCOHOL LINALOOL, (+/-)- CARRAGEENAN LEMON PEEL FERRIC OXIDE RED

Package label principal display panel

The content of the principal display panel of the product package, usually including the product’s name, dosage forms, and other key information about the drug product.
image of a carton

Do not use

Information about all contraindications for use. These contraindications are absolute and are intended for situations in which consumers should not use the product unless a prior diagnosis has been established by a doctor or for situations in which certain consumers should not use the product under any circumstances regardless of whether a doctor or health professional is consulted.
Do not use on damaged or broken skin

Keep out of reach of children

Information pertaining to whether the product should be kept out of the reach of children, and instructions about what to do in the case of accidental contact or ingestion, if appropriate.
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Stop use

Information about when use of the drug product should be discontinued immediately and a doctor consulted. Includes information about any signs of toxicity or other reactions that would necessitate immediately discontinuing use of the product.
Stop use and ask a doctor if rash occurs

When using

Information about side effects that people may experience, and the substances (e.g. alcohol) or activities (e.g. operating machinery, driving a car) to avoid while using the drug product.
When using this product keep out of eyes. Rinse with water to remove.

Safe handling warning

Safe Handling Warning
Flammable until dry. Avoid fire, flame and heat during application.

Storage and handling

Information about safe storage and handling of the drug product.
Other information protect the product in this container from excessive heat and direct sun

Warnings

Information about serious adverse reactions and potential safety hazards, including limitations in use imposed by those hazards and steps that should be taken if they occur.
Warnings For external use only

Disclaimer: Do not rely on openFDA or Phanrmacy Near Me to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Source: OpenFDA, Healthporta Drugs API